336 related articles for article (PubMed ID: 27832096)
1. MR Spectroscopy in Prostate Cancer: New Algorithms to Optimize Metabolite Quantification.
Bellomo G; Marcocci F; Bianchini D; Mezzenga E; D'Errico V; Menghi E; Zannoli R; Sarnelli A
PLoS One; 2016; 11(11):e0165730. PubMed ID: 27832096
[TBL] [Abstract][Full Text] [Related]
2. A phase and frequency alignment protocol for 1H MRSI data of the prostate.
Wright AJ; Buydens LM; Heerschap A
NMR Biomed; 2012 May; 25(5):755-65. PubMed ID: 21953616
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional proton magnetic resonance spectroscopic imaging with and without an endorectal coil: a prostate phantom study.
Ma C; Chen L; Scheenen TW; Lu J; Wang J
Acta Radiol; 2015 Nov; 56(11):1342-9. PubMed ID: 25348479
[TBL] [Abstract][Full Text] [Related]
4. Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.
Carlani M; Mancino S; Bonanno E; Finazzi Agrò E; Simonetti G
Radiol Med; 2008 Aug; 113(5):670-88. PubMed ID: 18493829
[TBL] [Abstract][Full Text] [Related]
5. Proton MR spectroscopy of the prostate.
Mueller-Lisse UG; Scherr MK
Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
[TBL] [Abstract][Full Text] [Related]
6. Quantitative (1) H MR spectroscopic imaging of the prostate gland using LCModel and a dedicated basis-set: correlation with histologic findings.
García-Martín ML; Adrados M; Ortega MP; Fernández González I; López-Larrubia P; Viaño J; García-Segura JM
Magn Reson Med; 2011 Feb; 65(2):329-39. PubMed ID: 20939087
[TBL] [Abstract][Full Text] [Related]
7. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978
[TBL] [Abstract][Full Text] [Related]
8. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.
Zakian KL; Eberhardt S; Hricak H; Shukla-Dave A; Kleinman S; Muruganandham M; Sircar K; Kattan MW; Reuter VE; Scardino PT; Koutcher JA
Radiology; 2003 Oct; 229(1):241-7. PubMed ID: 12920178
[TBL] [Abstract][Full Text] [Related]
9. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil.
Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Wright AJ; Barentsz JO; Heerschap A; Scheenen TW
Eur Urol; 2011 Nov; 60(5):1074-80. PubMed ID: 21419565
[TBL] [Abstract][Full Text] [Related]
10. Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer -- investigation of a correlation with Gleason score.
Selnaes KM; Gribbestad IS; Bertilsson H; Wright A; Angelsen A; Heerschap A; Tessem MB
NMR Biomed; 2013 May; 26(5):600-6. PubMed ID: 23280546
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
[TBL] [Abstract][Full Text] [Related]
12. Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology.
Créhange G; Parfait S; Liegard M; Maingon P; Ben Salem D; Cochet A; Funes de la Vega M; Cormier L; Bonnetain F; Mirjolet C; Brunotte F; Walker PM
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1087-94. PubMed ID: 20615624
[TBL] [Abstract][Full Text] [Related]
13. Reduced power magnetic resonance spectroscopic imaging of the prostate at 4.0 Tesla.
Near J; Romagnoli C; Bartha R
Magn Reson Med; 2009 Feb; 61(2):273-81. PubMed ID: 19165876
[TBL] [Abstract][Full Text] [Related]
14. In vivo prostate magnetic resonance spectroscopic imaging using two-dimensional J-resolved PRESS at 3 T.
Kim DH; Margolis D; Xing L; Daniel B; Spielman D
Magn Reson Med; 2005 May; 53(5):1177-82. PubMed ID: 15844143
[TBL] [Abstract][Full Text] [Related]
15. Effect of gold marker seeds on magnetic resonance spectroscopy of the prostate.
Hossain M; Schirmer T; Richardson T; Chen L; Buyyounouski MK; Ma CM
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):451-8. PubMed ID: 22245188
[TBL] [Abstract][Full Text] [Related]
16. Metabolite ratios in 1H MR spectroscopic imaging of the prostate.
Kobus T; Wright AJ; Weiland E; Heerschap A; Scheenen TW
Magn Reson Med; 2015 Jan; 73(1):1-12. PubMed ID: 24488656
[TBL] [Abstract][Full Text] [Related]
17. [1H magnetic resonance spectroscopy of the prostate].
Mueller-Lisse UG; Scherr M
Radiologe; 2003 Jun; 43(6):481-8. PubMed ID: 12827263
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging.
Kurhanewicz J; Vigneron DB; Hricak H; Parivar F; Nelson SJ; Shinohara K; Carroll PR
Radiology; 1996 Aug; 200(2):489-96. PubMed ID: 8685346
[TBL] [Abstract][Full Text] [Related]
19. MR spectroscopy of the prostate at 3T: measurements of relaxation times and quantification of prostate metabolites using water as an internal reference.
Weis J; Ortiz-Nieto F; Ahlström H
Magn Reson Med Sci; 2013 Dec; 12(4):289-96. PubMed ID: 24172792
[TBL] [Abstract][Full Text] [Related]
20. Temporal B0 field variation effects on MRSI of the human prostate at 7 T and feasibility of correction using an internal field probe.
Arteaga de Castro CS; Boer VO; Luttje MP; van der Velden TA; Bhogal A; van Vulpen M; Luijten PR; van der Heide UA; Klomp DW
NMR Biomed; 2014 Nov; 27(11):1353-60. PubMed ID: 25212868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
